These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2242568

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Determination of hydroxyproline polypeptides in urine and blood serum by gel filtration.
    Dubovsky J, Meyer RD.
    Clin Chim Acta; 1975 Jul 23; 62(2):277-86. PubMed ID: 1097133
    [Abstract] [Full Text] [Related]

  • 25. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP, Robitaille P, Vanasse M, Qureshi IA, Marescau B.
    Nephron; 1995 Jul 23; 69(4):411-7. PubMed ID: 7777105
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis.
    Pastor MC, Sierra C, Bonal J, Teixidó J.
    Am J Nephrol; 1993 Jul 23; 13(4):238-43. PubMed ID: 8267019
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Parathyroid hormone immunoreactivity in the plasma filtrate of uremic patients.
    Tsutsumi M, Fukase M, Fujita T, Fujita K, Inoue S, Shin J.
    Miner Electrolyte Metab; 1982 Mar 23; 7(3):146-50. PubMed ID: 7169980
    [Abstract] [Full Text] [Related]

  • 35. Clinical availability of serum fructosamine measurement in diabetic patients with uremia. Use as a glycemic index in uremic diabetes.
    Shoji T, Tabata T, Nishizawa Y, Kikunami K, Matsushita Y, Inoue T, Kenmotsu M, Miki T, Morii H.
    Nephron; 1989 Mar 23; 51(3):338-43. PubMed ID: 2918945
    [Abstract] [Full Text] [Related]

  • 36. Characterization of uremic "middle molecular" fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography.
    Schoots AC, Mikkers FE, Claessens HA, De Smet R, Van Landschoot N, Ringoir SM.
    Clin Chem; 1982 Jan 23; 28(1):45-9. PubMed ID: 7055936
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Separation and quantification of the "middle molecules" in uremia.
    Chapman GV, Ward RA, Farrell PC.
    Kidney Int; 1980 Jan 23; 17(1):82-8. PubMed ID: 7374022
    [Abstract] [Full Text] [Related]

  • 39. [Continuous ambulatory peritoneal dialysis in patients with diabetes mellitus].
    Ermolenko VM, Melikian AM, Ivashchenko MA, Shutov EV, Zenchenko IV.
    Ter Arkh; 2000 Jan 23; 72(6):55-7. PubMed ID: 10900652
    [Abstract] [Full Text] [Related]

  • 40. [Assessment of nutrition in dialysis patients and chronic uremic patients].
    Liu H, Duan X, Li G.
    Zhonghua Nei Ke Za Zhi; 1997 Nov 23; 36(11):727-30. PubMed ID: 10451942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.